Preventing Blindness Through Vaccination

Every minute, a child somewhere in the world is at risk of going blind from a disease that a simple vaccine can prevent. Measles – often dismissed as a routine childhood illness – is, in fact, one of the leading causes of childhood blindness worldwide. When combined with poor nutrition, particularly a lack of Vitamin A, the consequences for a child’s eyesight can be permanent and devastating. Understanding how these two preventable conditions – measles and Vitamin A deficiency – drive childhood blindness is the first step toward stopping them.

Measles and the eyes: more than just a rash
The deadly synergy between measles and Vitamin A deficiency
Understanding Vitamin A deficiency and xerophthalmia
Who is most at risk?
Vaccination: the most powerful line of defence
The role of vaccine hesitancy and access barriers
Vitamin A supplementation programmes
A three-pronged approach to prevention
Why the double burden matters for disability prevention

Measles and the eyes: more than just a rash

Most people associate measles with fever, coughing, and a distinctive red rash. What is far less known is the serious damage the virus can do to a child’s eyes. As many as 60,000 children are estimated to develop measles-related blindness each year in low-income countries, and the virus is most likely to cause blindness in those who have not been vaccinated.

The measles virus attacks the eye through several pathways. The most common and dangerous is keratitis – an infection of the cornea, the transparent front surface of the eye. Left untreated, keratitis causes ulcers on the cornea, which heal over with scar tissue. When these ulcers heal, they can leave opaque scar tissue that obstructs vision and causes blindness. In rarer cases, the virus can also damage the retina (retinopathy) or inflame the optic nerve (optic neuritis), both of which can cause permanent vision loss.

The deadly synergy between measles and Vitamin A deficiency

The situation becomes far worse when a child is also deficient in Vitamin A. There is a close synergism between measles and Vitamin A deficiency that can result in xerophthalmia, corneal ulceration, keratomalacia, and subsequent corneal scarring. Measles infection itself depletes the body’s Vitamin A stores rapidly, so even a child who was previously borderline deficient can plunge into severe deficiency during a measles episode.

Keratomalacia – a softening and liquefaction of the cornea caused by severe Vitamin A depletion – is particularly catastrophic. It can cause the eyeball to perforate and leads to irreversible blindness within days. Corneal lesions of this nature are a medical emergency, and once significant structural damage has occurred, no surgical intervention can fully restore vision.

Understanding Vitamin A deficiency and xerophthalmia

Vitamin A is not just a nutrient – it is essential for the structural integrity of the eye’s surface and for the functioning of the retina. Without adequate levels, the conjunctiva and cornea begin to dry out and break down. Xerophthalmia is the clinical spectrum of ocular manifestations of Vitamin A deficiency, ranging from night blindness and Bitot’s spots in milder stages, to the potentially blinding stages of corneal ulceration and keratomalacia.

Night blindness – difficulty seeing in low-light conditions – is often the first warning sign. It is followed by conjunctival xerosis (drying of the white of the eye), the appearance of Bitot’s spots (foamy grey patches on the conjunctiva), and ultimately, corneal breakdown. An estimated 250,000 to 500,000 children who are Vitamin A-deficient become blind every year, and half of them die within 12 months of losing their sight. These are not statistics about a distant, uncontrollable tragedy – they describe a wholly preventable crisis.

Who is most at risk?

Vitamin A deficiency disproportionately affects children under five and pregnant women in low- and middle-income countries, particularly in sub-Saharan Africa and South and Southeast Asia. Each year, anywhere from 20,000 to 100,000 new cases of blindness still occur in many parts of Africa due to xerophthalmia alone. Poverty, food insecurity, infectious disease burden, and limited access to healthcare all converge to raise the risk. Crucially, increased incidence of xerophthalmia has been observed after outbreaks of measles – meaning the two conditions frequently strike together, compounding the damage to children’s eyesight.

Vaccination: the most powerful line of defence

Preventing measles through vaccination is, without question, the single most effective intervention for preventing measles-related blindness. Accelerated immunization activities by countries and international partners successfully prevented an estimated 59 million deaths between 2000 and 2024, with measles deaths dropping from 780,000 in 2000 to 95,000 in 2024. This extraordinary progress is entirely attributable to expanded vaccination coverage.

The measles-mumps-rubella (MMR) vaccine – and its variants including the MR and MMRV formulations – has been in use since the 1960s. It is safe, effective, and inexpensive, and the WHO recommends two doses for all children as the standard for national immunization programmes. The first dose is typically given at 9 to 15 months of age, depending on local measles transmission rates, with a second dose administered later in childhood to ensure full immunity.

Despite this, coverage gaps remain. The proportion of children receiving a first dose of measles vaccine was 84% globally in 2024 – still below the 2019 level of 86%. And critically, between 2020 and 2025, more than 100 countries experienced measles outbreaks – a direct consequence of vaccination disruptions and growing vaccine hesitancy. Every unvaccinated child is a child at risk of measles-related blindness.

The role of vaccine hesitancy and access barriers

Vaccination coverage is undermined not only by poor health infrastructure but also by misinformation and cultural beliefs. In parts of Ethiopia, families have reported believing that measles was “normal” – that every child would contract it at some point in their life – and that vaccination would cause harm. These beliefs are not unique to one country. They represent a global challenge that education and community engagement must address alongside the logistics of vaccine delivery.

Vitamin A supplementation programmes

Where Vitamin A deficiency is prevalent, supplementation programmes are a critical complement to vaccination. A short-term emergency measure for at-risk populations involves the administration of single, large doses of Vitamin A on a periodic basis, while longer-term strategies include dietary fortification and food-based approaches.

The WHO’s guidance is clear: all children diagnosed with measles should receive two doses of Vitamin A supplements given 24 hours apart, as this restores depleted Vitamin A levels and can help prevent eye damage and blindness. High-dose oral Vitamin A supplementation – 200,000 IU for children over 12 months, and 100,000 IU for children aged 6 to 12 months – is the established protocol.

The impact of supplementation extends beyond the eyes. Treatment in early stages can restore vision, but in patients with corneal ulcers, surgery is required, and this still does not guarantee full restoration of vision. This is why routine supplementation – before damage occurs – is far preferable to reactive treatment. Public health interventions such as Vitamin A supplementation reached 59% of targeted children in 2022, indicating that while progress is being made, large numbers of children remain unprotected.

A three-pronged approach to prevention

Nutritional supplementation, rehabilitation, and education constitute a three-pronged approach in the management of Vitamin A deficiency. Health education that promotes the inclusion of Vitamin A-rich foods – such as orange and yellow fruits and vegetables, leafy greens, eggs, and dairy – in children’s diets is a sustainable long-term solution. Fortification of staple foods such as cooking oil, sugar, and flour with Vitamin A is a medium-term strategy already implemented in many countries. And targeted high-dose supplementation campaigns remain the most immediate and scalable emergency response, particularly during and after measles outbreaks.

Why the double burden matters for disability prevention

Measles-related blindness and Vitamin A deficiency blindness are not separate problems – they are deeply interconnected, and they fall hardest on the same populations: children in low-income countries with limited access to nutritious food, healthcare, and immunization services. Fewer than 10% of children with visual impairments in lower-income countries have access to education, meaning that preventable blindness does not just take a child’s sight – it takes their future.

From the perspective of disability studies and inclusive education, this matters enormously. Blindness acquired through measles or Vitamin A deficiency is not an inevitable biological outcome. It is the result of systemic inequities in access to vaccines, nutrition, and healthcare. Strategies to reduce this burden must include surveillance for measles and associated vision impairment, linkages for intervention and therapy, and convergence between primary health and eye care structures.

Teachers, health educators, and community workers have a direct role to play – in dispelling vaccine misinformation, encouraging families to seek early treatment for measles symptoms, and advocating for nutrition programmes that protect children’s sight before damage begins. Prevention here is not a medical abstraction. It is a practical, achievable goal, and it starts with awareness.

What do you think? In communities where vaccine hesitancy and food insecurity coexist, which do you believe should be prioritised first – expanding immunization outreach or strengthening nutritional support programmes? And how can educators and community health workers work together to reduce the burden of preventable childhood blindness?

References

PDF 📄

Table of Contents

Measles and the eyes: more than just a rash 🔗

The deadly synergy between measles and Vitamin A deficiency 🔗

Understanding Vitamin A deficiency and xerophthalmia 🔗

Who is most at risk? 🔗

Vaccination: the most powerful line of defence 🔗

The role of vaccine hesitancy and access barriers 🔗

Vitamin A supplementation programmes 🔗

A three-pronged approach to prevention 🔗

Why the double burden matters for disability prevention 🔗